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Aim. To examine medical practices and training needs of Que´bec family physicians with respect to pain management and
opioid prescription for chronic noncancer pain (CNCP). Methodology. An online survey was carried out in 2016. Results. Of 636
respondents (43.0%men; 54.3% ≥ 50 years old), 15.2% and 70.9% felt very or somewhat confident that they could properly prescribe
opioids for CNCP. Concerns related to abuse (72.5% strongly/somewhat agree), dependence (73.2%), and lack of support (75.4%)
were themain barriers reported.Only 19.7% always/often screened their patients for risks of abuse anddependence using a screening
tool. About two-thirds of participants (65.7%) had recently (last five years) taken part in continuing education programs on opioid
use forCNCPand 73.4%onCNCPmanagement. Patient evaluation anddifferential diagnoses of chronic pain syndromeswere rated
as a top priority for further training. Conclusions. This study provides insights into Que´bec family physicians’ concerns, practices,
and needs with respect to the management of CNCP. Physicians’ difficulties around the application of strategies to mitigate the
problem of opioid abuse and addiction are worrying. The need to better train physicians in the field of pain and addiction cannot
be emphasized enough.
1. Introduction
Chronic pain is a significant health problem in many coun-
tries with prevalence rates ranging from 10% to more than
50% [1–3]. One area of major concern is the high related
societal costs, estimated to be in billions annually in many
western countries [4, 5]. In Canada, the most recent estimate
of the prevalence of chronic pain among adults was 18.9%
in 2007-2008 [3]. Healthcare costs (excluding societal costs
related to disability and lost productivity) can be expected to
rise from $6.02 billion to $10.29 billion per year by 2025 [6].
Few studies have assessed the long-term benefits of
opioids for chronic pain [7]. Yet, opioids are commonly
prescribed and a sharp increase in prescriptions has been
observed over the last two decades in North America [8, 9].
This has resulted inmajor adverse public health consequences
ranging from diversion, abuse, dependence, and addiction
to fatal overdoses [10–14]. In the province of Que´bec, where
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this study took place, a report from the Institut National
de Sante´ Publique du Que´bec revealed that, between 2000
and 2012, mortality due to poisoning by opioids increased
by 6.5% a year in men and 8.7% a year in women [13, 15].
In Canada, recent work by Fischer et al. (2014) showed
that there was considerable heterogeneity among provinces
regarding quantities and types of prescription opioids (POs)
dispensed and that Que´bec was the province with the lowest
dispensing level [16].The study did not allow explaining these
differences and, apart from Canadian studies that included
small numbers of Que´bec physicians [17, 18], little is known
about Que´bec physicians’ beliefs and practices with respect
to chronic noncancer pain (CNCP) management. The most
recent study, carried out in 2009, looked at a small sample
(𝑛 = 137) of physicians identified as analgesics prescribers
and assessed their knowledge, attitudes, and beliefs regard-
ing CNCP [19]. Results showed suboptimal scores on all
aspects of pain management, including initial assessment,
definition of treatment goals and expectations, development
of a treatment plan, and reassessment and management of
longitudinal care. In 2009, the Colle`ge des Me´decins du
Que´bec posted guidelines for opioid use for chronic pain [20].
Since then, no studies have examined Que´bec physicians’
current practices and training needs in the field.
In light of this knowledge gap, this study sought to
determine whether physician prescribing habits conform
to Colle`ge des Me´decins du Que´bec guidelines for opioid
prescription for chronic noncancer pain, to identify barriers
to opioid use in the treatment of chronic noncancer pain, and
to assess training needs of physicians regarding pain man-
agement and prescription of pain medication.This study falls
under themandate of l’Institut National de Sante´ Publique du
Que´bec and its partners, theColle`ge desMe´decins duQue´bec
(CMQ), the Centre de Recherche et d’Aide pourNarcomanes,
and the University of Sherbrooke; this study was funded by
Health Canada in 2014.
2. Methods
An online survey was carried out among physicians prac-
ticing in the province of Que´bec in 2015. Participants who
identified themselves as family physicians and reported that
they prescribed opioids for chronic noncancer pain were
selected for this study. The Montre´al Public Health Depart-
ment’s Research Ethics Board provided a waiver from ethics
review for the survey.
2.1. Questionnaire Design. The questionnaire design was
based on a review of the literature including scientific papers
and, when available, study questionnaires that addressed
topics relevant to the survey objectives. A list of over a hun-
dred questions was developed; an initial selection was made,
based on the study objectives and the context of Que´bec
physicians’ practices (e.g., type of practice setting). A set of
questions—used as originally formulated or adapted—was
assembled into a first draft of the study questionnaire (in
French) and then submitted for consultation to a group of
experts in the field including an anesthesiologist who heads a
pain clinic, a family doctor trained in pain management, and
a pharmacist. The group was asked to check the length of the
questionnaire, whichwas not to exceed 15minutes, its fluidity,
clarity, and potential for bias. A new version was produced
and then reviewed by Ipsos, an independent market research
company hired to support the research team.Thefinal version
of the questionnaire was translated into English by Ipsos, and
the translation was verified by two physicians whose mother
tongue was English.
The questionnaire was divided into sections pertaining
to each of the study objectives. Section 1 included three
questions on certification in pain medicine, methadone,
and buprenorphine prescribing. An additional question
addressed the number of patients the physician treats per
week and the percentage of these patients requiring CNCP
intervention. Section 2 collected information about perceived
barriers to prescribing as well as physicians’ practices and
compliance with the CMQ guidelines. Potential barriers were
examined by assessing physicians’ levels of concern about
a series of factors that might cause a physician to avoid
or become hesitant about prescribing opioid analgesics for
CNCP. Physicians were also asked if they felt confident
that they could properly (1) prescribe opioid analgesics for
CNCP and (2) treat patients with CNCP. For both series
of questions, they indicated whether they strongly agreed,
somewhat agreed, somewhat disagreed, or strongly disagreed
with the statement.
Two questions addressed physicians’ choices of medi-
cation in cases of mild to moderate pain. Several options
of opioids were proposed in their short- or long-acting
versions, including codeine with or without acetaminophen,
hydrocodone, hydromorphone, meperidine, morphine, oxy-
codone with or without acetaminophen, tramadol with or
without acetaminophen, butorphanol nasal spray, tapentadol,
methadone, buprenorphine transdermal patch, and fentanyl
transdermal patch. The following products were proposed as
possible adjuvants for coanalgesia: acetaminophen, anticon-
vulsants, antidepressants, nonsteroidal anti-inflammatory
drugs, hypnotic sedatives or tranquilizers, medical mari-
juana, medical synthetic cannabinoid, and muscle relaxants.
Participants were asked how often they prescribed any of
those medications as the first-line treatment, using a four-
item Likert scale with the following choices: always, often,
occasionally, and never. No precision was provided to par-
ticipants regarding the frequencies to which these choices
corresponded.
Using the same four-item Likert scale, compliance to
CMQ guidelines was assessed, asking participants how often
they did each of a series of 12 actions, listed in the CMQ
guidelines. Section 3 asked about clinicians’ appreciation of
the quality of their academic training in the field of pain
and whether they had participated in related continuing
education programs in the past five years. Physicians were
also asked to identify their perceived learning needs and
preferences regarding the format and content for a continuing
education program. To do so, they were asked to rank the
main topics out of eight by training priority and to do the
same with a list of special populations (e.g., adolescents,
pregnant women, and CNCP patients with mental health
disorders) for whom they might want to receive training in
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CNCP management. Lastly, participants were asked to rank
different tools in terms of relevance to facilitate decision-
making as to whether or not opioid analgesics should be
prescribed. Questions in Section 4 addressed the physicians’
sociodemographic profile (age, sex, and practice location)
and practice characteristics (specialty, practice type, and
patient volume).
2.2. Data Collection. Physicians were invited to participate in
the survey through a “newsletter” that the CMQ sent by e-
mail to all its members; it described the survey and included
information about anonymity. According to the CMQ, 20,983
physicians out of a total of 22,153 subscribed to the newsletter.
Physicians were invited to click on a link that brought them to
an intranet web site managed by Ipsos. Only physicians who
practice clinical medicine were invited to fill out the whole
questionnaire.
To improve participation, the CMQ sent the invitation
twice, one week apart.The survey was also promoted through
several channels including the Fe´de´ration des Me´decins
Omnipraticiens du Que´bec’s newsletter, personal solicitation
of the presidents of several medical specialty associations of
the Fe´de´ration des Me´decins Spe´cialistes du Que´bec, and the
professional services of the Centres Inte´gre´s de Sante´ et de
Services Sociaux and Centres Inte´gre´s Universitaires de Sante´
et de Services Sociaux, thus including all health and social
services at the core of Que´bec’s public health system.
2.3. Statistical Analyses. Data were analyzed using weighted
proportions according to age and sex distribution of all
Que´bec family physicians. For the Likert scales, proportions
are reported for single or aggregated categories. Analyses
were performed using SAS 9.4.
3. Results
The survey took place between October 14, 2015, and
November 17, 2015. A total of 1,111 individuals completed the
questionnaire, but 19 were excluded because of incomplete
or incoherent answers. Of the 1,092 participating physicians,
653 identified themselves as family physicians, including
636 who reported that they prescribed opioid analgesics at
least occasionally to their patients with CNCP. Given the
convenience sampling strategy used in this survey and the
anonymity of the process, it is not possible to estimate the
rate of refusal to participate. According to the CMQdatabase,
9,285 family physicians were active during the survey period;
therefore, the participation rate is estimated to be 7.03%.
Whether remote or urban, all health regions were well
represented, with almost a quarter of the sample (24.56%)
practicing on the island of Montre´al. Table 1 shows that
the sex and age distribution of the overall family physician
population and the sample were similar.
Table 2 describes the clinical practice profile of survey
participants. The majority (74.9%) had been practicing for 10
years ormore at the time of survey andmost were quite active
with over two-thirds (66.9%) reporting that they treated
at least 50 patients a week. A significant number (43.7%)
were practicing in hospitals, half in family medicine groups,
Table 1: Sex and age distribution of the Que´bec family physician
population and sample (𝑁 = 636).
Family
physician
population¥ (%)
Survey
participants (%)
Male 46 43.0
Age
≤29 years 6 5.8
30–39 years 20 20.0
40–49 years 19 20.0
50–59 years 29 29.4
60–69 years 21 20.4
≥70 years 5 4.5
¥Data provided by Colle`ge des Me´decins du Que´bec.
about a third in private clinics, and a quarter in community
clinics. More than half of the participants were involved in
clinical teaching (54.8%) and nearly 20% had an exemption
to prescribe methadone, mostly for pain. To the question on
number of patients seen in a week, 33.0% of the physicians
answered 49 and under, 50.6% answered 50 to 99, 14.8%
answered 100 to 149, and 1.6% answered 150 and over. For
each of these categories, the proportions of patients requiring
interventions for CNCP were estimated to be 85.9%, 87.1%,
89.5%, and 62.7%, respectively.
The majority of participants felt at ease working in the
field of pain. Most answered that they were confident they
could properly prescribe opioid analgesics for CNCP (15.2%
strongly agreed and 70.9% somewhat agreed). They also felt
confident that they could properly treat patients with CNCP
(11.8% strongly agreed and 66.0% somewhat agreed).
To the question about which opioid analgesic physicians
chose as a first-line treatment in cases of mild to moderate
noncancer chronic pain, 28.7% reported that they never
(1.6%) or only occasionally (27.1%) prescribed one of the
proposed medications. More than a third of the sample
(34.5%) never (1.6%) or occasionally (32.9%) prescribed
immediate-release or short-acting opioids, and 51.8% of
the sample (never: 12.6%; occasionally: 39.2%) prescribed
extended-release or long-acting opioids. Few participants
(3.1%) reported that they never or occasionally prescribed
coanalgesia. Regarding which opioids participants preferred,
morphine and hydromorphone were the most popular
immediate-release or short-acting opioids, followed by tra-
madol with acetaminophen and codeinewith acetaminophen
combinations (Table 3). As for extended-release or long-
acting opioids, again morphine and hydromorphone were
first, followed by fentanyl patches, oxycodone, and tramadol.
Of the 12 factors (Table 4) proposed that could cause
participants to avoid or hesitate in prescribing opioid anal-
gesics forCNCP, threewere chosenmost often by participants
who reported strongly or somewhat agreeing with the state-
ments: lack of professional support in the event of abuse or
dependence (75.4%), risk of dependence (73.2%), and risk of
abuse, misuse, and diversion among patients (72.5%). Many
participants were also worried about risks of other cognitive
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Table 2: Clinical practice profile of survey participants (𝑁 = 636).
Number %∗
Number of years in clinical practice¥
≤4 years 97 13.85
5–9 years 73 11.3
10–14 years 44 7.4
15–19 years 62 11.04
20–24 years 71 11.3
≥25 years 288 45.2
Current location of clinical practice
Hospital 278 43.7
Emergency department 95 14.9
Outpatient clinic 50 7.97
Inpatient clinic 213 33.4
Local community service centre (CLSC) 154 23.8
Residential and long-term care centre (CHSLD) 105 16.5
Family medicine group (FMG) 328 51.5
Private clinic 223 35.7
Group 164 26.2
Solo 60 9.7
Clinical teaching‡
Yes 347 54.8
No 282 45.2
Number of patients per weekm
≤49 211 33.1
50–99 320 50.5
100–149 93 14.8
≥150 10 1.5
Has full exemption to prescribe methadone
Yes, for pain 65 10.34
Yes, for substitution treatment 24 3.63
Yes, for both pain and substitution treatment 32 5.25
No 515 80.77
∗Weighted proportions; ¥1 missing; ‡7 missing; m2 missing.
and physical effects of opioids, lack of support (e.g., pain
specialist, psychologist, or clinical pharmacist) for patients
during pain treatment, and difficulty with making a good
diagnosis.
Table 5 shows that compliance with CMQ guidelines
was variable. Actions recommended in case of abuse or
dependence were the least often reported with only 4.9%,
19.7%, and 20.0% of participants, respectively, answering that
they often/always ask patients at risk of becoming dependent
to provide urine samples to test for drugs, evaluate risks of
dependence using a screening tool, and have patients at risk
of becoming dependent sign treatment contracts. Rates of
compliance were much higher for other CMQ recommended
actions but remained suboptimal overall.
Participants were quite critical regarding their academic
training, with a majority reporting that their university
education related to opioid analgesics prescribing practices
for CNCP was “not very” (41.7%) or “not at all” (29.2%)
adequate; only 3.6% chose the category “very adequate.” In
terms of university education for patient CNCPmanagement,
44.3% reported that their training was “not very,” 29.4%
“not at all,” and 2.9% “very” adequate. However, a majority
had attended continuing education programs in the past five
years, including 65.7% related to opioid analgesic prescription
practices for patients with CNCP and 73.4% for CNCP
management.
Training needs related to “patient evaluation and differ-
ential diagnoses of chronic pain syndromes” were identified
as the top priority (Table 6). Nearly one-third of participants
rated this topic as their first choice and almost two-thirds
chose it as one of their six priorities of eight proposed topics.
Three other topics were rated as first priorities by at least
10% of the sample or identified as one of the six priorities;
in descending order, these topics are “evaluating and man-
aging the risks of abuse, misuse, dependence, tolerance, and
diversion,” “indications and uses of alternative medications
to opioids,” and “indications and uses of various opioids.”
Monitoring of patient pain was also considered an important
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Table 3: Prescription opioid preferences.
Always Frequently Occasionally Never
%∗ %∗ %∗ %∗
Short-acting drugs
Morphine 1.2 34.7 48.9 15.3
Hydromorphone 1.25 33.2 48.9 16.7
Tramadol/acetaminophen 1.02 23.7 51.0 24.3
Codeine/acetaminophen 1.1 18.1 44.9 36.0
Oxycodone 0.7 13.7 47.4 38.3
Tramadol 0.3 14.1 44.3 41.4
Codeine 0.5 7.3 35.4 56.9
Oxycodone/acetaminophen 0.2 3.7 23.4 72.8
Hydrocodone 0.4 1.7 11.0 87.0
Tapentadol 0.2 1.1 10.2 88.5
Meperidine 0.2 0.6 9.1 90.2
Nasal butorphanol 0 0.4 1.5 98.1
Long-acting drugs
Morphine 1.0 25.1 45.2 28.8
Hydromorphone 0.5 26.4 38.8 34.4
Transdermal fentanyl 0.3 15.5 42.1 42.0
Oxycodone 0.3 12.0 44.8 42.9
Tramadol 0.2 14.9 41.8 43.1
Codeine 0 5.1 27.6 67.3
Transdermal buprenorphine 0.2 3.0 21.8 75.1
Tapentadol 0.3 1.7 9.9 88.5
Methadone 0 2.0 5.6 92.5
∗Weighted proportions.
Table 4: Barriers to opioid analgesic prescription (𝑁 = 636).
Strongly
agree
Somewhat
agree
Somewhat
disagree
Strongly
disagree
Does not
apply
%∗ %∗ %∗ %∗ %∗
Difficulty in properly
evaluating/establishing a clear diagnosis
of CNCP
13.1 41.7 32.7 10.8 1.7
Extra work linked to opioid treatment 6.34 23.2 42.9 24.9 2.3
CNCP patients tend to be “heavy cases” 13.2 34.2 31.9 18.2 2.6
Adverse effects 19.62 50.1 24.6 4.8 1.0
Risk of abuse, misuse, or diversion 26.9 45.6 22.9 3.6 1.1
Risk of dependence 29.3 43.9 20.4 5.3 1.2
Risk of overdose 11.7 35.0 41.5 10.3 1.6
Risk of tolerance 16.8 41.7 31.2 9.5 0.8
Lack of professional support in treating
the pain 30.0 36.2 24.1 7.9 1.8
Lack of professional support in the event
of abuse or dependence 36.1 39.3 17.2 4.8 2.7
Risk of inspection or professional
sanctions 3.3 15.1 40.2 39.2 2.3
Lack of proof that opioid analgesics are
effective for CNCP in the long term 8.6 28.4 41.7 18.2 3.10
∗Weighted proportions.
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Table 5: Rates of compliance to the CMQ guidelines (𝑛 = 636).
Always Frequently Sometimes Never Not applicable
%∗ %∗ %∗ %∗ %∗
Prescribe a urine test for drug testing to patients at risk 1.0 3.9 21.6 62.0 11.5
Assess risk of dependence using a screening tool 5.11 14.6 35.7 44.5 —
Sign a contract with patients at risk 7.4 12.7 25.2 42.4 12.4
Perform a psychosocial assessment 23.6 35.8 32.2 8.5 —
Use a scale to assess the intensity of pain 28.9 37.7 26.9 6.5 —
Use a tracking sheet 52.4 17.3 15.0 15.3 —
Assess patient’s overall level of function 35.3 43.4 16.6 4.7 —
Inform patients & their close contacts of the risks 46.3 36.7 13.2 3.8 —
Develop a treatment plan with follow-ups 48.9 35.8 12.8 2.5 —
Progressively reduce the dosage when the patient improves 45.4 40.2 11.9 2.4 —
Discuss additional or alternative treatments 51.6 36.6 10.7 1.2 —
Do a complete anamnesis 70.5 23.3 5.9 0.2 —
∗Weighted proportions.
Table 6: Participants’ priorities of training needs (𝑁 = 636).
Top
priority
%∗
One of the
six
priorities
%∗
Topics§
Indications and uses of various opioids 17.7 43.1
Indications and uses of alternative medications to opioids 14.1 45.2
Evaluating and managing the risks of abuse, misuse, dependence, tolerance, and diversion 13.7 46.4
Evaluating and managing side effects 2.5 16.8
Patient evaluation and differential diagnoses of chronic pain syndromes 31.7 60.5
Monitoring patient pain (patient reevaluation, treatment plan adjustment, etc.) 8.7 40.9
Indications and uses of nonpharmacological approaches (psychotherapy, physiotherapy, occupational therapy, etc.) 5.0 24.3
Indications and methods for referring patients to a multidisciplinary pain clinic 6.2 23.4
Other 0.4 —
Special populations§
Infants and toddlers 0.2 1.6
Preschoolers 0.46 1.0
School-age children 0.1 3.3
Adolescents 0.6 10.61
Pregnant women 2.0 9.5
CNCP patients with mental health disorders 30.3 9.5
Patients with a history of drug abuse 25.9 91.4
Seniors 40.5 90.1
∗Weighted proportions; §12 missing.
topic, with 40.1% of participants indicating that it was one of
their six choices for training needs. Training need priorities
also clearly targeted special populations: seniors, patients
withmental disorders, and those with a history of drug abuse.
Finally, participants’ choices regarding teaching methods
were diverse (Table 7). The top priority was scientific oral
presentations such as conferences and lectures, with 31.9%
indicating the latter method as their preferred one and nearly
60% as one of their six choices of eight possibilities. As for
tools that would assist their decisions to prescribe opioid
analgesics, access to a free telephone or online consultation
service with a medical expert was the first choice for 41.4% of
participants. Access to other online resources was selected by
41.2%, with 28.6% choosing online reference tools onQue´bec
or Canadian medical guidelines concerning opioid use for
CNCP and 12.6% choosing online directories of resources
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Table 7: Priorities of teaching methods (𝑛 = 636).
Teaching methods§ Top priority%∗
One of the six
priorities
%∗
Interactive classroom activities (problem-based learning, case study discussions, etc.) 20.0 44.7
Scientific oral presentations (conferences, lectures, etc.) 31.9 59.9
Webinars (online presentations) 6.8 32.6
Intensive courses (classroom-based) 4.1 18.4
Online courses with tutoring 5.8 19.3
Online self-study modules without tutoring 12.2 42.4
Self-study modules (on paper) 4.5 23.3
Internship in a pain management clinic 7.4 21.9
Videos on the best practices for prescribing opioid analgesics 7.2 37.7
∗Weighted proportions; §5 missing.
and references on CNCP management and use of opioids.
Prescription monitoring programs and free telephone or
online consultation services with pharmaceutical experts
were the first choices of 10.2% and 6.3% of participants,
respectively.
4. Discussion
This is the first study addressing the practices and training
needs of Que´bec family physicians in the field of CNCP.
One of the main findings relates to what appears to be a
discrepancy between physicians’ concerns regarding risks
of patient opioid abuse and dependence and physicians’
actual practices. Only a minority always/often screened their
patients for those risks using a screening tool, although
concerns related to complications and lack of support in
pain management were the main barriers to prescribing.
Furthermore, almost half (46.4%) identified training on
abuse and dependence risks assessment and management as
one of their top three priorities, but only 13.7% ranked it
first. The high level of concern reported about the potential
for abuse and dependence is consistent with many previous
studies [17, 18, 21–24].This is understandable considering that
the risk is real, with reported addiction or addiction-related
aberrant behavior rates ranging from 8% to 26% among
patients with chronic pain [25]. However, the reason for
the discrepancy between physicians’ concerns and practices
is not clear and merits further investigation. It should be
underlined that a recent CDC review shows that accuracy
of risk assessment instruments for predicting opioid abuse
or misuse was inconsistent or limited and no study has
evaluated the effectiveness of risk mitigation strategies [7].
This situation might undermine physicians’ confidence in
current guidelines.
Our study shows that compliance of family physicians
practices with CMQ guidelines was generally suboptimal
for detection of risks and management of opioid abuse and
dependence, but also for other recommendations. Many
physicians did not systematically apply most recommenda-
tions, either for evaluation or for monitoring of patients
and their conditions. Several studies showed low compliance
with guidelines among physicians, indicating that merely
disseminating guidelines is not a guarantee of good practices
[19, 26]. Moreover, significant differences exist between avail-
able guidelines, which could explain the physicians’ varied
responses.
Similar to other studies, the majority of participants felt
at least somewhat confident that they could properly treat
patients and prescribe opioid analgesics forCNCP [17, 22, 27].
Yet, they rated their academic training on pain as relatively
poor. This apparent contradiction might be explained by the
observed high proportion of participants who had partici-
pated in continuing education programs in the five years prior
to the survey. Constantly encountering patients with chronic
pain may lead physicians to compensate for their deficient
university training in this area. According to the literature,
pain education for North American medical students is
limited, variable, and fragmented [28].These findings call for
more effort on the part of universities and certifying boards
to improve physicians’ knowledge and practices in the field of
pain.
Studies show that many physicians consider that more
education is essential to improve pain management, and they
value these programs highly [19, 22]. In this study, more than
two-thirds of participants had taken continuing education
programs on opioid analgesic prescription practices and
nearly three-quarters on chronic CNCP management. As for
training needs, considering the aging population, it is reassur-
ing to observe that physicians identified seniors as the priority
group among the special populations proposed.This involves
training on the specific needs of this particularly vulnerable
population, especially regarding dosage, monitoring, and
drug interactions. Aside from the subject of “patient evalu-
ation and differential diagnoses of chronic pain syndromes,”
picked by one-third of the sample as the number one training
priority, training themes were diverse and addressed several
topics mostly related to indications and uses of medications
(opioids per se and alternative medications to opioids). This
might reflect poor training in these areas, perceived or real,
among family physicians in Que´bec. It might also signal
certain ignorance of the alternatives to medications or the
perception that these are other professionals’ responsibilities.
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Unfortunately, despite great interest from physicians, there
is still limited evidence that educational interventions alone
have long-term positive impacts on prescribing practices
[29]. Research into effective education strategies remains a
priority and recent work investigating appropriate modalities
is promising [30]. Face-to-face activities seem to be the most
popular option among Que´bec family physicians. Identifying
methods that are both appealing and efficient to reach a large
number of physicians remains a challenge.
It is possible that though necessary, continuing educa-
tion is not sufficient; perhaps reinforcement and supportive
measures are needed. In this study, the resource considered
most relevant to deciding to prescribe opioids was access to a
free telephone or online consultation service with a medical
expert (42%).This is consistent with Allen et al.’s study (2013)
which showed that 84% of Canadian family physicians found
this “enabling factor” important to improve their practices
[17]. Although in that study participants did not have to
choose the most relevant factor, this choice was second
in terms of frequency. Implementing and broadening such
consultation services remain a challenge given that experts in
pain medicine are rare in Canada. Financial and legal aspects
of remote expert consultation also need to be addressed to
ensure these services are used and ultimately improve the care
of patients with CNCP.
Only 10% of the survey participants considered prescrip-
tion monitoring programs as relevant to their decisions to
prescribe opioids, a sharp contrast with the figure of 87%
found by Allen et al. [17]. It should bementioned that Que´bec
does not have a prescription monitoring program yet, which
could explain these results. However, perhaps upgrading and
adapting the Dossier Sante´ Que´bec (an electronic platform
provided by the Ministe`re de la Sante´ et des Services Sociaux
du Que´bec) could be done; this source already contains
clinical information about prescribed medications for each
patient consulting a physician in the province. Finally, free
telephone or online access to clinical pharmacist consultants
was the first choice of only 6% of our survey participants.
Pharmacists have played an important safety role in vali-
dating and distributing POs and monitoring drug therapy
of their patients for years, and this contribution should be
enhanced and valued [31]. Moreover, clinical pharmacists
already provide painmanagement consultations to inpatients
and outpatients (e.g., palliative care, postoperative care) [32–
34]. Improved training in detection and management of
patients with addiction problems and infrastructures to facil-
itate their clinical practices in community settings [35, 36]
are needed. Interdisciplinary work emphasizing physician-
pharmacist collaboration should also be strongly encouraged
[31].
A substantial number of physicians often or always pre-
scribed POs as a first-line choice in cases of mild to moderate
CNCP. Among participants who prescribed POs, morphine
and hydromorphone were the most popular choices either
as short- or as long-acting formulations. It should be noted
that, in Que´bec, tramadol and buprenorphine patches are
not covered by the public drug reimbursement program.
Furthermore, codeine is generally not recommended because
of frequent drug interactions and risks of toxicity due to
CYP2D6 polymorphisms. About two-thirds of participants
reported that they prescribed fentanyl patches even as a first-
linemedication; this is somewhat surprising, since fentanyl is
generally recommended for moderate to severe pain.
This study has a number of limitations. Participants
were not randomly recruited and the participation rate
was only 7%, thereby limiting the generalizability of our
findings. Family physicians doing clinical teaching and those
prescribing methadone were overrepresented in the sample,
which suggests that physicians who are more interested and
have better training in the field of CNCP and prescription
opioids responded. However, the sample of participants was
fairly large and comparable to the population of reference
with respect to age and sex distribution. Furthermore, data
were collected through self-reports, which could have led
to a social desirability bias. Yet, the impact of such bias
was probably limited by the anonymity of the study. Due
to anonymity, it was impossible to prevent or check for
duplicate participation.However, there is no reason to believe
that physicians completed the survey several times. More
research is needed to better understand the complexity of
physicians’ prescribing behaviours [37]. However, the results
show that Que´bec physicians are generally comparable to
other physicians both within the country and elsewhere,
at least in terms of barriers, compliance to guidelines, and
training needs.
In conclusion, this study provides important insights into
Que´bec family physicians’ concerns, practices, and needs
with respect to CNCP management. It also sheds light on
difficulties around the application of current strategies tomit-
igate the problem of misuse, abuse, and addiction to opioid
drugs and its consequences.The need to better educate physi-
cians in the field of pain starting from the predoctoral level
cannot be emphasized enough. Basic training in the field of
addiction should also be provided to all physicians. Further-
more, it is increasingly obvious that better pain management
requires an interdisciplinary approach. The contribution of
other health professionals with complementary expertise,
including clinical pharmacists, nurses, physiotherapists, and
psychotherapists, should be encouraged.
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